PharmTech Europe September 2026

Progress depends not only on discovery, but on how effectively the industry captures, shares, and applies what it has already learned.

The EU is focused on strengthening supply-chain resilience, avoiding medicine shortages, simplifying regulations, and implementing new approach methodologies.

European biotechs are advancing bioinks and high-resolution bioprinting for medical devices and regenerative tissues.

PharmTech spoke with Jamie Evans, manager of analytical method development and validation, and Joe Cobb, CPIP, manager of formulations, both with Lonza Capsugel, about best practices for pharmaceutical technology transfer.

The established safety profiles, dosing regimens, and manufacturing pathways of repurposed generics can significantly shorten timelines and reduce costs as alternative cancer therapies.